Tag Archives: remedies

misbehavior in Amazon reviews + false ingredient claims = $9.5 million award

Posted on November 12, 2020 by

Vitamins Online, Inc. v. HeartWise, Inc. 2020 WL 6581050, No. 13-cv-00982-DAK (D. Utah Nov. 10, 2020) This is a long-running supplement false advertising case involving both ingredient and “review” claims; here the district court resolves a number of issues, finding … Continue reading →

Posted in Uncategorized | Tagged , , | Leave a comment

lack of irreparable harm dooms injunction against false advertising of drug disposal product

Posted on October 19, 2020 by

In re C2R Global Manufacturing, Inc., No. 18-30182-beh, 2020 WL 5941330 (E.D. Wisc. Bkcy Oct. 6, 2020) Verde sought a preliminary injunction against C2R, its direct competitor in the drug disposal market, from engaging in false and misleading advertising in … Continue reading →

Posted in Uncategorized | Tagged , | Leave a comment

inability to rely on claims provides standing to seek injunctive relief in 9th Circuit

Posted on September 30, 2020 by

Milan v. Clif Bar & Co., 2020 WL 5760450, No. 18-cv-02354-JD (N.D. Cal. Sept. 28, 2020) Plaintiffs brought the usual California claims against the “health and wellness message[s]” on defendant Clif Bar & Company’s “Kid Zbars” and “ ‘Classic’ Clif … Continue reading →

Posted in Uncategorized | Tagged , , , , | Leave a comment

restitution unavailable in fed ct when damages are adequate, no matter what Cal state cts say

Posted on September 24, 2020 by

Sonner v. Premier Nutrition Corp., 971 F.3d 834 (9th Cir. 2020) In this amended opinion (original summarized here), the court elaborates on its reasoning that Sonner couldn’t abandon her damages claim on the eve of trial in this false advertising … Continue reading →

Posted in Uncategorized | Tagged , , , , | Leave a comment

Expedia’s unavailability claims sometimes literally false, maybe misleading; materiality is contested for trial

Posted on September 15, 2020 by

Buckeye Tree Lodge v. Expedia, Inc., 2020 WL 5372246, No. 16-cv-04721-VC (N.D. Cal. Sept. 9, 2020) The court denies cross motions for summary judgment on whether Expedia violated the Lanham Act by suggesting that plaintiffs’ hotels could in theory be … Continue reading →

Posted in Uncategorized | Tagged , , | Leave a comment

seller’s private definition of “Made in USA” fails; disgorgement appropriate

Posted on September 9, 2020 by

Newborn Bros. Co. v. Albion Engineering Co., 2020 WL 5015571, No. 12-2999 (NLH/KMW) After a bench trial, the court found Albion liable for falsely advertising its caulk dispensing guns as “Made in the USA” (a bit ironic given the name, … Continue reading →

Posted in Uncategorized | Tagged , | Leave a comment

inhaler marketing is partly deceptive; P not required to resurvey revised material

Posted on September 8, 2020 by

GlaxoSmithKline LLC v. Boehringer Ingelheim Pharms., Inc., 2020 WL 5258317, No. 19-5321 (E.D. Pa. Sept. 3, 2020) GSK partially succeeded and partially failed to preliminarily enjoin some of BI’s marketing in this case involving claims about different inhalers. Of broader … Continue reading →

Posted in Uncategorized | Tagged , | Leave a comment

deceptive resort fee case against Marriott survives

Posted on August 18, 2020 by

Hall v. Marriott Int’l, Inc., No. 19-CV-1715 JLS (AHG), 2020 WL 4727069 (S.D. Cal. Aug. 14, 2020) A class action against Marriott for deceptive “resort” and other added fees that make the total price of a hotel room impossible to … Continue reading →

Posted in Uncategorized | Tagged , , | Leave a comment

continued claim, including failure to edit existing YouTube video, leads to contempt finding

Posted on August 17, 2020 by

De Simone v. VSL Pharmaceuticals, Inc., 2020 WL 4368103, No. TDC-15-1356 (D. Md. Jul. 30, 2020) Disclosure: I filed an amicus brief in support of De Simone on one legal issue (the proper standard for a Lanham Act literal falsity … Continue reading →

Posted in Uncategorized | Tagged , , , | Leave a comment

9th Cir. revives suit against allegedly deceptive “prescription pet food” marketing

Posted on August 17, 2020 by

Moore v. Mars Petcare US, Inc., No. 18-15026, — F.3d —-, 2020 WL 4331765 (9th Cir. Jul. 28, 2020) Over a dissent, the court of appeals reversed the dismissal of plaintiffs’ claims based on allegedly deceptive marketing of “so-called prescription … Continue reading →

Posted in Uncategorized | Tagged , , , | Leave a comment